[323 Pages Report] The global closed system transfer devices market is estimated to reach US$ 872 Million in 2022, and anticipated to reach US$ 3800 Million by 2032, due to the technological advancements for effective delivery of healthcare service. As per FMI, the closed system transfer devices market is likely to exhibit the said growth at a CAGR of 18.1% during the forecast period from 2022 to 2032.
Report Attribute | Details |
---|---|
Closed System Transfer Devices Market Anticipated Forecast Value (2022) | US$ 872 Million |
Closed System Transfer Devices Market Anticipated Forecast Value (2032) | US$ 3800 Million |
Closed System Transfer Devices Market Projected Growth Rate (2022 to 2032) | 18.1% CAGR |
The global closed system transfer devices market is said to garner significant growth owing to one of the key reasons, which is the increasing prevalence of cancer. Chemotherapy is the primary procedure for cancer and therefore results in escalated use of CSTDs for administering or transferring agents, which might pose a health risk to healthcare workers.
During chemotherapy, there could be surface contamination which can adversely affect not just the healthcare workers but also the patients and their helpers. The demand for closed system transfer devices has increased with the rising cases of all types of cancer, which has resulted in more chemotherapy treatment.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
For the treatment of cancer, antineoplastic drugs are broadly used and are termed extremely harmful. Healthcare workers engaged in preparing, transporting, distributing, administering, i.e., pre-, and post-administering, and disposing of these drugs are potentially at a higher risk of its adverse effects on their health.
The closed system transfer devices market trends and forecast suggest that key factors driving the growth of this market are increasing cases of cancer, increased oncology drug approvals, enhancing regulatory guidelines pertaining to handling and using harmful drugs safely and constant advancements in technology.
In 2017, as per World Cancer Research Fund, nearly 50 million individuals across the world suffered from some type of cancer.
In 2012, the cumulative five-year incidence of cancers across all populations was projected to be 32.6 million across the globe. Several government bodies like The Occupational Safety and Health Administration, The Oncology Nursing Society, and ASHP, amongst others, stated a list of guidelines for handling harmful drugs more safely. This resulted in increased demand for closed system transfer devices, and that eventually boosted the global market growth.
Rising cases of gastrointestinal stromal tumours (GIST) are also a factor fueling the global closed system transfer devices market growth. The American Society of Clinical Oncology published data that stated that approximately 4000 to 6000 adults in the United States are diagnosed with GIST every year. This could escalate the demand for closed system transfer devices as they can be used in compounding and administering chemotherapy drugs.
To train pharmacists involved in compounding procedures, recently, there has been an invention of lean management principles in healthcare. This will amplify the closed system transfer devices market size during the forecast period.
Increasing prominence on implementing safety measures for laboratory personnel is anticipated to promote the growth of the closed system transfer devices market during the forecast period.
Furthermore, the rise in the number of fatal accident cases owing to exposure to harmful chemicals and drugs is anticipated to boost closed system transfer device opportunities during the forecast period.
Besides all the driving factors, the closed system transfer devices market is said to have several markets hindering factors. Closed system transfer devices are expensive and are a global hindrance to their widespread use.
Lack of reimbursement policy and lack of awareness amongst healthcare workers pertaining to the harmful risks involved with lethal drug handling are factors that are obstructing the use of closed system transfer devices and will hamper the growth of this market.
Additionally, the COVID-19 pandemic resulted in reduced chemotherapy procedures across the world since various hospitals and clinics were redirected towards accommodating COVID-19 patients. These undue procedures led to a major backlog owing to accelerating COVID-19 cases and thus negatively impacted the market.
Region-wise North America is said to hold the biggest market share in the closed system transfer devices market owing to greater awareness of CSTDs in amongst the oncologists. In North America, several initiatives are taken by the U.S. Food and Drug Administration and several other regulatory bodies to assure safety of the patients along with a greater number of oncology drug approvals.
Furthermore, advanced technologies are easily accessible in this region and besides the oncologists, even the nurses and pharmacists are skilled and well-trained in handling the harmful drugs and these factors fuel the growth of this market in North America.
Following North America, Asia Pacific region is anticipated to experience biggest CAGR during the forecast period owing to increased use of CSTDs due to growing number of cancer cases, demand for better healthcare services, and more international players are aiming towards emerging markets like China and India.
Some of the most prominent companies in the global Closed System Transfer Devices market are ICU Medical, Inc., Equashield LLC, Becton, Simplivia Healthcare, Dickinson and Company, B. Braun Melsungen AG, Corvida Medical, Yukon Medical, Baxter International Inc., and others.
In January 2021, Simplivia Healthcare achieved a 70% share of NOVAMED which is a diagnostic company which effectively develops and manufactures a variety of diagnostic kits to meet the growing trends of home care sufficiently.
Report Attribute | Details |
---|---|
Growth rate | CAGR of 18.1% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 to 2020 |
Forecast period | 2022 to 2032 |
Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
Segments covered | Component, End User, Region |
Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
Key companies profiled | ICU Medical, Inc.; Equashield LLC; Becton; Dickinson and Company; B. Braun Melsungen AG; Simplivia Healthcare; Corvida Medical; Yukon Medical; Baxter International Inc. |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global closed system transfer devices market is estimated to grow at a CAGR of 18.1% from 2022 to 2032.
North America is the key region accountable for highest revenue generation in this market.
ICU Medical, Inc., Equashield LLC, Becton, Dickinson and Company, B. Braun Melsungen AG, Simplivia Healthcare, Corvida Medical, Yukon Medical, Baxter International Inc., and others.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product, 2022-2032 5.3.1. Systems 5.3.1.1. Needle Free Systems 5.3.1.2. Needle Systems 5.3.2. Component 5.3.2.1. Vial Adaptors 5.3.2.2. Syringe Adaptors 5.3.2.3. Tubing Sets and Accessories 5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022-2032 6.3.1. Pharmacy 6.3.2. Nursing 6.3.3. Veterinary 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Distribution Channel, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Distribution Channel, 2022-2032 7.3.1. Direct Sales 7.3.2. Distributors 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Chile 10.2.1.5. Peru 10.2.1.6. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Rest of Asia Pacific 12.2.2. By Product 12.2.3. By Application 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Turkey 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Product 13.2.3. By Application 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product 14.1.2.2. By Application 14.1.2.3. By Distribution Channel 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product 14.2.2.2. By Application 14.2.2.3. By Distribution Channel 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product 14.3.2.2. By Application 14.3.2.3. By Distribution Channel 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product 14.4.2.2. By Application 14.4.2.3. By Distribution Channel 14.5. Argentina 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product 14.5.2.2. By Application 14.5.2.3. By Distribution Channel 14.6. Chile 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product 14.6.2.2. By Application 14.6.2.3. By Distribution Channel 14.7. Peru 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product 14.7.2.2. By Application 14.7.2.3. By Distribution Channel 14.8. Germany 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product 14.8.2.2. By Application 14.8.2.3. By Distribution Channel 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product 14.9.2.2. By Application 14.9.2.3. By Distribution Channel 14.10. France 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product 14.10.2.2. By Application 14.10.2.3. By Distribution Channel 14.11. U.K. 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product 14.11.2.2. By Application 14.11.2.3. By Distribution Channel 14.12. Spain 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product 14.12.2.2. By Application 14.12.2.3. By Distribution Channel 14.13. Russia 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product 14.13.2.2. By Application 14.13.2.3. By Distribution Channel 14.14. BENELUX 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product 14.14.2.2. By Application 14.14.2.3. By Distribution Channel 14.15. China 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product 14.15.2.2. By Application 14.15.2.3. By Distribution Channel 14.16. Japan 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product 14.16.2.2. By Application 14.16.2.3. By Distribution Channel 14.17. South Korea 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product 14.17.2.2. By Application 14.17.2.3. By Distribution Channel 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Product 14.18.2.2. By Application 14.18.2.3. By Distribution Channel 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Product 14.19.2.2. By Application 14.19.2.3. By Distribution Channel 14.20. Turkey 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Product 14.20.2.2. By Application 14.20.2.3. By Distribution Channel 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product 15.3.3. By Application 15.3.4. By Distribution Channel 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. ICU Medical, Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Baxter International, Inc. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. B. Braun Melsungen AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Becton, Dickinson and Company 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Equashield LLC 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Corvida Medical 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Yukon Medical 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Caragen Ltd. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. JMS Co. Ltd. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports